ArticleKidney international2020
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
Article in Kidney international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.Medicina (Kaunas, Lithuania) · 2021Pooled it
- COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.Transplantation reviews (Orlando, Fla.) · 2021Pooled it
- Review
- Erythrodermic psoriasis in post-coronavirus disease 2019 patient.Asia Pacific allergy · 2022Article
- Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?Renal failure · 2021Review
- The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19.Pharmaceuticals (Basel, Switzerland) · 2021Review
- COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.The Journal of pathology · 2021Review
- In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2.Open forum infectious diseases · 2021Article
- Impact of COVID-19 in solid organ transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021Review
- A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing.Nature machine intelligence · 2021Article
- Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.Therapeutic advances in gastroenterology · 2021Article
- Kidney transplant recipients infected by COVID-19: Review of the initial published experience.Transplant infectious disease : an official journal of the Transplantation Society · 2020Review
- A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts.Journal of clinical medicine · 2020Review
- Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic.Actas dermo-sifiliograficasArticle
Corrections and comments
- Comment on
- Comment on
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.